Nxera Pharma Co Ltd (4565) Stock Price & News

4565:TYO

Nxera Pharma Co Ltd

¥1,520.00

-4.10%

(-65.00) 1D

Nov 4, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Last report

Oct 30, 2026

Fiscal period

Q3 2026

- / -

Revenue / Est. (JPY)

8.83B / 7.60B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in JPY

Loading Previous Earnings...

All values in JPY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	7.77B	11.26B	7.65B	8.83B
Cost of goods sold	2.05B	1.12B	2.16B	988.00M
Cost of revenue	2.05B	1.12B	2.16B	988.00M
Research and development expenses	3.27B	3.03B	2.97B	2.95B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	363.00M	3.57B	3.38B	1.38B
Operating expense	8.08B	6.89B	6.85B	6.55B
Total operating expenses	10.13B	8.01B	9.02B	7.54B
Operating income	-2.36B	3.24B	-1.36B	1.29B
Other non operating income	-5.02B	-2.00M	2.00M	1.00M
EBT including unusual items	-8.11B	3.04B	-1.64B	1.16B
EBT excluding unusual items	-6.30B	3.04B	-1.64B	1.16B
Income tax expense	-391.00M	1.25B	-1.44B	428.00M
Effective tax rate	4.82%	41.08%	87.71%	36.74%
Other operating expenses	996.00M	295.00M	499.00M	217.00M
Net income	-7.72B	1.79B	-202.00M	737.00M
Net profit margin	-99.41%	15.93%	-2.64%	8.34%
Earnings per share	-	-	-	-
Interest and investment income	1.06B	144.00M	-	110.00M
Interest expense	-	-287.00M	-488.00M	-61.00M
Net interest expenses	1.06B	-143.00M	-488.00M	49.00M
Depreciation and amortization charges	3.45B	-	-	2.01B
EBITDA	-1.28B	4.35B	-268.00M	2.36B
Gain or loss from assets sale	1.16B	-	1.21B	503.00M

Finance